Roche, Life Technologies and Illumina Lead Next-Generation Sequencing Market
Online, June 16, 2011 (Newswire.com) - The sequencing technology market is estimated to be worth over $1 billion on an annual basis. Key players leading this market include Illumina, Roche, and Life Technologies. Accounting for nearly 60% of revenues, Illumina is currently the market leader. Illumina's sequencing by synthesis (SBS) technology is the most widely-adopted next-generation sequencing platform in the world. SBS technology is the only platform offering both short-insert paired-end capability and long-insert paired-end reads. Using a combination of these two technologies increases the ability to completely characterize any genome. Short-inserts are used for high-resolution genome sequencing while longer reads are utilized for efficient sequence assemble, de novo sequencing and large-scale structural variation detection.
Companies are continuously seeking to advance in cost and performance in the Next Generation Sequencing (NGS) space. Growing market adoption and application diversity are two trends characterizing the fast-progressing NGS market. The new Insight Pharma report examines new and upcoming products from the following companies: Illumina, Life Technologies, Complete Genomics, Roche/454 Life Sciences, Helicos BioSciences, Pacific BioSciences and Ion Torrent.
The report also features a section on NGS systems and technologies on the horizon, meaning still in research or in development and have not yet crossed the commercial feasibility hurdle. According to Insight Pharma, the bulk of this category can be considered extensions of second-generation technologies, while a few represent a significant advance in performance and cost-effectiveness. The report analyzes 14 corporate programs (Illumina Avantome, Oxford Nanopore Technologies, GnuBio, NABsys, NobleGen, Halcyon Molecular, IBM, GE Global Research, Life Technologies Starlight, and more) and 2 academic research programs in this area.
For more information, please visit: http://www.the-infoshop.com/report/cd199300-next-generation-sequencing-generates-momentum.html or e-mail [email protected]
Contact Us
Telephone:
Toll Free (US & CANADA): +1-866-353-3335
Outside US: +1-860-674-8796
Email: [email protected]
Address: 195 Farmington Avenue, Suite 208 - Farmington, CT 06032 USA
Website: http://www.the-infoshop.com
Share:
Tags: biotechnology, DNA mapping, genome characterization, next-generation sequencing, NGS